Abstract
Mitogen-activated protein kinases ERK1 and ERK2 have been implicated in various pathophysiological events of the CNS, but their specific roles in cell processes under physiologic and pathological conditions remain to be determined. ERK1/2 was originally identified as a kinase activity that mediates neuronal survival and neuroprotection, but it was subsequently found that ERK1/2 also plays a critical role in neurodegeneration. This dichotomy makes it difficult to target ERK1/2 for neuroprotection. Accumulating evidence suggests that ERK1 and ERK2 may play distinct functions in a variety of cell fate decisions. In this review, I summarize recent evidence for distinct roles for individual ERK isoforms in pathophysiology of the CNS.
Original language | English |
---|---|
Pages (from-to) | 267-276 |
Number of pages | 10 |
Journal | Frontiers in Biology |
Volume | 7 |
Issue number | 3 |
DOIs | |
State | Published - Jun 2012 |
Bibliographical note
Funding Information:The author would like to thank Dr. James Geddes for comments on the manuscript. This research was supported by grants from the Paralysis Project of America and the Kentucky Spinal Cord and Head Injury Research Trust (#7-6A and 11-19A).
Keywords
- ERK isoform
- cell death
- cell proliferation
- neurodegeneration
- neuroprotection
ASJC Scopus subject areas
- Biotechnology
- Ecology, Evolution, Behavior and Systematics
- Ecology
- Genetics